Advances in researches of the preparative technology and targeting for albumin nanoparticles

Chinese Pharmaceutical Journal

Volumn 40, Issue 9, 2005, Pages 641-644

  Su, Hua ^a   Hu, Jin Hong ^a   Li, Feng Qian ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMPHOTERICIN B; BOVINE SERUM ALBUMIN; CYANURIC ACID; FLUORESCEIN ISOTHIOCYANATE; FLUOROURACIL; GANCICLOVIR; GLYCYRRHIZIC ACID; MACROGOL; MANNOSE 6 PHOSPHATE; METHOTREXATE; NANOPARTICLE; OVALBUMIN; PACLITAXEL; POLOXAMINE 908; SOLVENT;

ANEMOMETRY; ARTICLE; CONFOCAL LASER MICROSCOPY; DRUG FORMULATION; DRUG TARGETING; HYPERTHERMIA; PH; PROTEOMICS; RETICULOENDOTHELIAL SYSTEM; SPECTROSCOPY; STELLATE CELL; SURFACE PLASMON RESONANCE; TIME CORRELATED SINGLE PHOTON COUNTING SPECTROSCOPY;

EID: 22844447174     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Santhi K, Dhanaraj SA, Joseph V, et al. A study on the preparation and anti-tumor efficacy of bovine serum albumin nanospheres containing 5-fluorouracil [J]. Drug Dev Ind Pharm, 2002, 28(9): 1171.
2. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice [J]. Pharmacol Rev, 2001, 53(2): 283.
3. Langer K, Coester C, von Briesen H, et al. Preparation of avidin-labeled protein nanoparticles as carriers for biotinylated peptide nucleic acid (PNA) [J]. Eur J Pharm Biopharm, 2000, 49(3): 303.
4. Weber C, Kreuter J, Langer K. Preparation of surface modified protein nanoparticles by introduction of sulfhydryl groups [J]. Int J Pharm, 2000, 211(1-2): 67.
5. Coombes AGA, Breeze V, Wu Lin, et al. Lactic acid-stabilised albumin for microsphere formulation and biomedical coatings [J]. Biomaterials, 2001, 22: 1.
6. Weber C, Coester C, Kreuter J, et al. Desolvation process and surface characteristics of protein nanoparticles [J]. Int J Pharm, 2000, 194(1): 91.
7. Langer K, Balthasar S, Vogel V, et al. Optimization of the preparation process for human serum albumin (HSA) nanoparticles [J]. Int J Pharm, 2003, 257(1-2): 169.
8. Vogel V, Langer K, Balthasar S, et al. Characterization of serum albumin nanoparticles by sedimentation velocity analysis and electron microscopy [J]. Prog Colloid Polym Sci, 2002, 119: 31.
9. Santhi K, Dhanaraj SA, Rajendran SD, et al. Nonliposomal approach-a study of preparation of egg albumin nanospherescontaining amphotericin-B [J]. Drug Dev Ind Pharm, 1999, 25(4): 547.
10. Merodio M, Irache JM, Eclancher F, et al. Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release proterties [J]. Eur J pharm Sci, 2001, 12(3): 251.
11. Meziani MJ, Sun YP. Protein-conjugated nanoparticles from rapid expansion of supercritical fluid solution into aqueous solution [J]. J Am Chem Soc, 2003, 125(26): 8015.
12. Santhi K, Dhanaraj SA, Koshy M, et al. Study of biodistribution of methotrexate-loaded bovine serum albumin nanospheres [J]. Drug Dev Ind Pharm, 2000, 26 (12): 1293.
13. Moghimi SM. Chemical camouflage of nanospheres with a poorly reactive surface: towards development of stealth and target-specific nanocarriers [J]. Biochim Biophys Acta, 2002, 1590(1-3): 131.
14. Stella B, Arpicco S, Peracchia MT. Design of folic acid-conjugated nanoparticles for drug targeting [J]. J Pharm Sci, 2000, 89(11): 1452.
15. Beljaars L, Olinga P, Molema G, et al. Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin [M6P(28)-HSA] [J]. Law, 2001, 21(5): 320.
16. Wilhelm C, Billotey C, Roger J, et al. Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating [J]. Biomaterials, 2003, 24(6): 1001.
17. Alexiou C, Arnold W, Hulin P, et al. Magnetic nitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting [J]. J Magnetism Magn Mater, 2001, 225: 187.
18. Griffiths JR, Glickson JD. Monitoring pharmacokinetics of anticancer drugs: non-invasive investigation using magnetic resonance spectroscopy [J]. Adv Drug Deliv Rev, 2000, 41: 75.
19. Wartlick H, Schmitt BS, Strebhardt K, et al. Tumour cell delivery of antisense oligonucleotides by human serum albumin nanoparticles [J]. J Controlled Release, 2004, 96: 483.
20. Xie H, Tkachenko AG, Glomm WR, et al. Critical flocculation concentrations, binding isotherms, and ligand exchange properties of peptide-modified gold nanoparticles studied by UV-visible, fluorescence, and time-correlated single photon counting spectroscopies [J]. Anal Chem, 2003, 75(21): 5797.
21. Stich N, Gandhum A, Matyushin V, et al. Phage display antibodybased proteomic device using resonance-enhanced detection [J]. J Nanosci Nanotechnol, 2002, 2(3-4): 375.
22. Moghimi SM, Pavey KD, Hunter AC. Real-time evidence of surface modification at polystyrene lattices by poloxamine 908 in the presence of serum: in vivo conversion of macrophage-prone nanoparticles to stealth entities by poloxamine 908 [J]. FEBS Lett, 2003, 547 (1-3): 177.
23. Haes AJ, van Duyne RP. A nanoscale optical biosensor: sensitivity and selectivity of an approach based on the localized surface plasmon resonance spectroscopy of triangular silver nanoparticles [J]. J Am Chem Soc, 2002, 124(35): 1059.
24. Damascelli B, Patelli GL, Lanocita R, et al. A novel intraarterial chemotherapy using paclitaxel in albumin nanoparticles to treat advanced squamous cell carcinoma of the tongue: preliminary findings [J]. AJR Am J Roentgenol, 2003, 181(1): 253.